3.8.0.1 html 203 327 1 false 69 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://acurapharm.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://acurapharm.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://acurapharm.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://acurapharm.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN ACCUMULATED STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://acurapharm.com/role/ConsolidatedStatementsOfChangesInAccumulatedStockholdersEquityDeficit CONSOLIDATED STATEMENTS OF CHANGES IN ACCUMULATED STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://acurapharm.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 107 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://acurapharm.com/role/OperationsAndSummaryOfSignificantAccountingPolicies OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 108 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://acurapharm.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 109 - Disclosure - LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTS Sheet http://acurapharm.com/role/LicenseDevelopmentAndCommercializationAgreements LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTS Notes 9 false false R10.htm 110 - Disclosure - INVENTORIES Sheet http://acurapharm.com/role/Inventories INVENTORIES Notes 10 false false R11.htm 111 - Disclosure - PROPERTY, PLANT AND EQUIPMENT Sheet http://acurapharm.com/role/PropertyPlantAndEquipment PROPERTY, PLANT AND EQUIPMENT Notes 11 false false R12.htm 112 - Disclosure - ACCRUED EXPENSES Sheet http://acurapharm.com/role/AccruedExpenses ACCRUED EXPENSES Notes 12 false false R13.htm 113 - Disclosure - DEBT Sheet http://acurapharm.com/role/Debt DEBT Notes 13 false false R14.htm 114 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://acurapharm.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 14 false false R15.htm 115 - Disclosure - EMPLOYEE BENEFIT PLAN Sheet http://acurapharm.com/role/EmployeeBenefitPlan EMPLOYEE BENEFIT PLAN Notes 15 false false R16.htm 116 - Disclosure - COMMON STOCK WARRANTS Sheet http://acurapharm.com/role/CommonStockWarrants COMMON STOCK WARRANTS Notes 16 false false R17.htm 117 - Disclosure - SHARE-BASED COMPENSATION EXPENSE Sheet http://acurapharm.com/role/SharebasedCompensationExpense SHARE-BASED COMPENSATION EXPENSE Notes 17 false false R18.htm 118 - Disclosure - NET LOSS PER SHARE Sheet http://acurapharm.com/role/NetLossPerShare NET LOSS PER SHARE Notes 18 false false R19.htm 119 - Disclosure - INCOME TAXES Sheet http://acurapharm.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 120 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://acurapharm.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 121 - Disclosure - SUBSEQUENT EVENT Sheet http://acurapharm.com/role/SubsequentEvent SUBSEQUENT EVENT Notes 21 false false R22.htm 122 - Disclosure - SUPPLEMENTARY DATA - QUARTERLY RESULTS OF OPERATION Sheet http://acurapharm.com/role/SupplementaryDataQuarterlyResultsOfOperation SUPPLEMENTARY DATA - QUARTERLY RESULTS OF OPERATION Notes 22 false false R23.htm 123 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://acurapharm.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 124 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://acurapharm.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://acurapharm.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 125 - Disclosure - INVENTORIES (Tables) Sheet http://acurapharm.com/role/InventoriesTables INVENTORIES (Tables) Tables http://acurapharm.com/role/Inventories 25 false false R26.htm 126 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) Sheet http://acurapharm.com/role/PropertyPlantAndEquipmentTables PROPERTY, PLANT AND EQUIPMENT (Tables) Tables http://acurapharm.com/role/PropertyPlantAndEquipment 26 false false R27.htm 127 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://acurapharm.com/role/AccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://acurapharm.com/role/AccruedExpenses 27 false false R28.htm 128 - Disclosure - DEBT (Tables) Sheet http://acurapharm.com/role/DebtTables DEBT (Tables) Tables http://acurapharm.com/role/Debt 28 false false R29.htm 129 - Disclosure - COMMON STOCK WARRANTS (Tables) Sheet http://acurapharm.com/role/CommonStockWarrantsTables COMMON STOCK WARRANTS (Tables) Tables http://acurapharm.com/role/CommonStockWarrants 29 false false R30.htm 130 - Disclosure - SHARE-BASED COMPENSATION EXPENSE (Tables) Sheet http://acurapharm.com/role/SharebasedCompensationExpenseTables SHARE-BASED COMPENSATION EXPENSE (Tables) Tables http://acurapharm.com/role/SharebasedCompensationExpense 30 false false R31.htm 131 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK (Tables) Sheet http://acurapharm.com/role/NetLossPerShareOfCommonStockTables NET LOSS PER SHARE OF COMMON STOCK (Tables) Tables 31 false false R32.htm 132 - Disclosure - INCOME TAXES (Tables) Sheet http://acurapharm.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://acurapharm.com/role/IncomeTaxes 32 false false R33.htm 133 - Disclosure - SUPPLEMENTARY DATA - QUARTERLY RESULTS OF OPERATION (Tables) Sheet http://acurapharm.com/role/SupplementaryDataQuarterlyResultsOfOperationTables SUPPLEMENTARY DATA - QUARTERLY RESULTS OF OPERATION (Tables) Tables http://acurapharm.com/role/SupplementaryDataQuarterlyResultsOfOperation 33 false false R34.htm 134 - Disclosure - OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Sheet http://acurapharm.com/role/OperationsAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Details 34 false false R35.htm 135 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Non-Cash Share-Based Compensation Expense (Detail) Sheet http://acurapharm.com/role/SummaryOfSignificantAccountingPoliciesNoncashSharebasedCompensationExpenseDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Non-Cash Share-Based Compensation Expense (Detail) Details 35 false false R36.htm 136 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Lives of the Major Classification of Depreciable Assets (Detail) Sheet http://acurapharm.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesOfMajorClassificationOfDepreciableAssetsDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Lives of the Major Classification of Depreciable Assets (Detail) Details 36 false false R37.htm 137 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk by Risk Factor (Detail) Sheet http://acurapharm.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskByRiskFactorDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk by Risk Factor (Detail) Details 37 false false R38.htm 138 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Sheet http://acurapharm.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Details 38 false false R39.htm 139 - Disclosure - LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTS - Additional Information (Detail) Sheet http://acurapharm.com/role/LicenseDevelopmentAndCommercializationAgreementsAdditionalInformationDetail LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTS - Additional Information (Detail) Details 39 false false R40.htm 140 - Disclosure - INVENTORIES - Schedule of Inventories (Detail) Sheet http://acurapharm.com/role/InventoriesScheduleOfInventoriesDetail INVENTORIES - Schedule of Inventories (Detail) Details 40 false false R41.htm 141 - Disclosure - INVENTORIES - Inventory Reserve (Detail) Sheet http://acurapharm.com/role/InventoriesInventoryReserveDetail INVENTORIES - Inventory Reserve (Detail) Details 41 false false R42.htm 142 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Detail) Sheet http://acurapharm.com/role/PropertyPlantAndEquipmentDetail PROPERTY, PLANT AND EQUIPMENT (Detail) Details http://acurapharm.com/role/PropertyPlantAndEquipmentTables 42 false false R43.htm 143 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Additional Information (Detail) Sheet http://acurapharm.com/role/PropertyPlantAndEquipmentAdditionalInformationDetail PROPERTY, PLANT AND EQUIPMENT - Additional Information (Detail) Details 43 false false R44.htm 144 - Disclosure - ACCRUED EXPENSES (Detail) Sheet http://acurapharm.com/role/AccruedExpensesDetail ACCRUED EXPENSES (Detail) Details http://acurapharm.com/role/AccruedExpensesTables 44 false false R45.htm 145 - Disclosure - DEBT - Summary of Debt (Detail) Sheet http://acurapharm.com/role/DebtSummaryOfDebtDetail DEBT - Summary of Debt (Detail) Details 45 false false R46.htm 146 - Disclosure - DEBT - Interest Expense (Detail) Sheet http://acurapharm.com/role/DebtInterestExpenseDetail DEBT - Interest Expense (Detail) Details 46 false false R47.htm 147 - Disclosure - DEBT - Additional Information (Detail) Sheet http://acurapharm.com/role/DebtAdditionalInformationDetail DEBT - Additional Information (Detail) Details 47 false false R48.htm 148 - Disclosure - RELATED PARTY TRANSACTIONS- Additional Information(Detail) Sheet http://acurapharm.com/role/RelatedPartyTransactionsAdditionalInformationdetail RELATED PARTY TRANSACTIONS- Additional Information(Detail) Details 48 false false R49.htm 149 - Disclosure - EMPLOYEE BENEFIT PLAN - Additional Information (Detail) Sheet http://acurapharm.com/role/EmployeeBenefitPlanAdditionalInformationDetail EMPLOYEE BENEFIT PLAN - Additional Information (Detail) Details 49 false false R50.htm 150 - Disclosure - COMMON STOCK WARRANTS - Schedule Of Common Stock Warrant Activity (Detail) Sheet http://acurapharm.com/role/CommonStockWarrantsScheduleOfCommonStockWarrantActivityDetail COMMON STOCK WARRANTS - Schedule Of Common Stock Warrant Activity (Detail) Details 50 false false R51.htm 151 - Disclosure - COMMON STOCK WARRANTS - Additional Information (Detail) Sheet http://acurapharm.com/role/CommonStockWarrantsAdditionalInformationDetail COMMON STOCK WARRANTS - Additional Information (Detail) Details 51 false false R52.htm 152 - Disclosure - SHARE-BASED COMPENSATION EXPENSE - Stock Option Award Activity (Detail) Sheet http://acurapharm.com/role/SharebasedCompensationExpenseStockOptionAwardActivityDetail SHARE-BASED COMPENSATION EXPENSE - Stock Option Award Activity (Detail) Details 52 false false R53.htm 153 - Statement - SHARE-BASED COMPENSATION EXPENSE - Summary of Information about Non Vested Stock Options (Detail) Sheet http://acurapharm.com/role/SharebasedCompensationExpenseSummaryOfInformationAboutNonVestedStockOptionsDetail SHARE-BASED COMPENSATION EXPENSE - Summary of Information about Non Vested Stock Options (Detail) Details 53 false false R54.htm 154 - Statement - SHARE-BASED COMPENSATION EXPENSE - Assumptions Used in Black-Scholes Model to Determine Fair Value for Stock Option Awards Granted (Detail) Sheet http://acurapharm.com/role/SharebasedCompensationExpenseAssumptionsUsedInBlackscholesModelToDetermineFairValueForStockOptionAwardsGrantedDetail SHARE-BASED COMPENSATION EXPENSE - Assumptions Used in Black-Scholes Model to Determine Fair Value for Stock Option Awards Granted (Detail) Details 54 false false R55.htm 155 - Statement - SHARE-BASED COMPENSATION EXPENSE - Summary of RSU Plan (Detail) Sheet http://acurapharm.com/role/SharebasedCompensationExpenseSummaryOfRsuPlanDetail SHARE-BASED COMPENSATION EXPENSE - Summary of RSU Plan (Detail) Details 55 false false R56.htm 156 - Disclosure - SHARE-BASED COMPENSATION EXPENSE - Additional Information (Detail) Sheet http://acurapharm.com/role/SharebasedCompensationExpenseAdditionalInformationDetail SHARE-BASED COMPENSATION EXPENSE - Additional Information (Detail) Details 56 false false R57.htm 157 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK (Details) Sheet http://acurapharm.com/role/NetLossPerShareOfCommonStockDetails NET LOSS PER SHARE OF COMMON STOCK (Details) Details http://acurapharm.com/role/NetLossPerShareOfCommonStockTables 57 false false R58.htm 158 - Disclosure - INCOME TAXES - Provision for Income Taxes (Detail) Sheet http://acurapharm.com/role/IncomeTaxesProvisionForIncomeTaxesDetail INCOME TAXES - Provision for Income Taxes (Detail) Details 58 false false R59.htm 159 - Disclosure - INCOME TAXES - Components of Our Deferred Tax Assets (Detail) Sheet http://acurapharm.com/role/IncomeTaxesComponentsOfOurDeferredTaxAssetsDetail INCOME TAXES - Components of Our Deferred Tax Assets (Detail) Details 59 false false R60.htm 160 - Disclosure - INCOME TAXES - Additional Information (Detail) Sheet http://acurapharm.com/role/IncomeTaxesAdditionalInformationDetail INCOME TAXES - Additional Information (Detail) Details 60 false false R61.htm 161 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Sheet http://acurapharm.com/role/CommitmentsAndContingenciesAdditionalInformationDetail COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Details 61 false false R62.htm 162 - Disclosure - SUBSEQUENT EVENT - Additional Information (Detail) Sheet http://acurapharm.com/role/SubsequentEventAdditionalInformationDetail SUBSEQUENT EVENT - Additional Information (Detail) Details 62 false false R63.htm 163 - Disclosure - SUPPLEMENTARY DATA - QUARTERLY RESULTS OF OPERATION (Details) Sheet http://acurapharm.com/role/SupplementaryDataQuarterlyResultsOfOperationDetails SUPPLEMENTARY DATA - QUARTERLY RESULTS OF OPERATION (Details) Details http://acurapharm.com/role/SupplementaryDataQuarterlyResultsOfOperationTables 63 false false All Reports Book All Reports acur-20171231.xml acur-20171231.xsd acur-20171231_cal.xml acur-20171231_def.xml acur-20171231_lab.xml acur-20171231_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true